{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:40Z","timestamp":1790803660472,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clgc.2023.04.013","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:02:41Z","timestamp":1683079361000},"page":"712.e1-712.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An Update on Focal Therapy for Prostate Cancer"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-0443","authenticated-orcid":false,"given":"Hector","family":"Ayerra Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Ferm\u00edn","family":"Barba Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Extramiana Cameno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February","key":"10.1016\/j.clgc.2023.04.013_bib0001","first-page":"212","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG. Guidelines on prostate cancer","volume":"53","author":"Mottet","year":"2021","journal-title":"Update"},{"issue":"SPEC. ISS. A","key":"10.1016\/j.clgc.2023.04.013_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1102\/1470-7330.2011.9003","article-title":"Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment","volume":"11","author":"Da Rosa","year":"2011","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","article-title":"Detection of clinically significant prostate cancer using magnetic resonance imaging \u2013 ultrasound fusion targeted biopsy\u202f: a systematic review","volume":"68","author":"Valerio","year":"2014","journal-title":"Eur Urol"},{"issue":"10071","key":"10.1016\/j.clgc.2023.04.013_bib0004","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","article-title":"Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis(figure presented.)","volume":"76","author":"Kasivisvanathan","year":"2019","journal-title":"Eur Urol"},{"issue":"19","key":"10.1016\/j.clgc.2023.04.013_bib0006","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0007","first-page":"1","article-title":"Focal therapy in prostate cancer: the current situation","volume":"8","author":"J\u00e1come-Pita","year":"2014","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00345-018-2364-x","article-title":"Ablation energies for focal treatment of prostate cancer","volume":"37","author":"Lodeizen","year":"2019","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/107327481302000305","article-title":"Focal cryotherapy in the treatment of localized prostate cancer","volume":"20","author":"Nguyen","year":"2013","journal-title":"Cancer Control"},{"issue":"4","key":"10.1016\/j.clgc.2023.04.013_bib0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.juro.2017.10.033","article-title":"Prospective multicenter phase II Study on focal therapy (hemiablation) of the prostate with high intensity focused ultrasound","volume":"199","author":"Ganzer","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2023.04.013_bib0011","first-page":"500","article-title":"The \u201cmale lumpectomy\u201d: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up","volume":"26","author":"Onik","year":"2008","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"11","key":"10.1016\/j.clgc.2023.04.013_bib0012","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1464-410X.2011.10578.x","article-title":"Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line database (COLD) registry","volume":"109","author":"Ward","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eururo.2012.03.006","article-title":"Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years","volume":"62","author":"Bahn","year":"2012","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2023.04.013_bib0014","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.urology.2007.02.047","article-title":"Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer","volume":"69","author":"Lambert","year":"2007","journal-title":"Urology"},{"issue":"6 SUPPL. 1","key":"10.1016\/j.clgc.2023.04.013_bib0015","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.urology.2007.07.036","article-title":"Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results","volume":"70","author":"Ellis","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)01643-6","article-title":"Focal \u201cnerve-sparing\u201d cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency","volume":"60","author":"Onik","year":"2002","journal-title":"Urology"},{"issue":"June","key":"10.1016\/j.clgc.2023.04.013_bib0017","first-page":"1","article-title":"Cryosurgery would be an effective option for clinically localized prostate cancer: a meta-analysis and systematic review","volume":"6","author":"Gao","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clgc.2023.04.013_bib0018","article-title":"Primary cryotherapy for localised or locally advanced prostate cancer","author":"Jung","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"49","key":"10.1016\/j.clgc.2023.04.013_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19490","article-title":"Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation","volume":"19","author":"Ramsay","year":"2015","journal-title":"Health Technol Assess (Rockv)"},{"key":"10.1016\/j.clgc.2023.04.013_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2020.07.012","article-title":"The impact of performing a 3D mapping biopsy prior to primary cryotherapy for the treatment of prostate cancer","volume":"144","author":"Barqawi","year":"2020","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.clgc.2023.04.013_bib0021","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.euf.2019.09.004","article-title":"Assessment of return to baseline urinary and sexual function following primary focal cryotherapy for nonmetastatic prostate cancer","volume":"7","author":"Shah","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0022","first-page":"131","article-title":"High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment","volume":"80","author":"Alkhorayef","year":"2015","journal-title":"Polish J Radiol"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0023","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/CCO.0000000000000515","article-title":"Contemporary treatments in prostate cancer focal therapy","volume":"31","author":"Ahdoot","year":"2019","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2023.04.013_bib0024","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1148\/radiol.2021202717","article-title":"MRI-guided Focused ultrasound ablation for localized intermediate-risk prostate cancer: early results of a phase II trial","volume":"298","author":"Ghai","year":"2021","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clgc.2023.04.013_bib0026","doi-asserted-by":"crossref","DOI":"10.1088\/0954-3899\/39\/4\/045006","article-title":"Magnetized strangelets at finite temperature","volume":"39","author":"Felipe","year":"2012","journal-title":"J Phys G Nucl Part Phys"},{"issue":"22","key":"10.1016\/j.clgc.2023.04.013_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25225417","article-title":"Developments in vascular-targeted photodynamic therapy for urologic malignancies","volume":"25","author":"Nogueira","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.prnil.2018.12.002","article-title":"Photodynamic therapy for prostate cancer: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2019","journal-title":"Prostate Int"},{"issue":"4","key":"10.1016\/j.clgc.2023.04.013_bib0029","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2018.05.121","article-title":"Randomized trial of partial gland ablation with vascular targeted phototherapy versus active surveillance for low risk prostate cancer: extended followup and analyses of effectiveness","volume":"200","author":"Gill","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.04.013_bib0030","doi-asserted-by":"crossref","unstructured":"Azzouzi A, Vincendeau S, Barret E, et\u00a0al. Padeliporfi n vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. 2016;2045(16):1-11. doi:10.1016\/S1470-2045(16)30661-1","DOI":"10.1016\/S1470-2045(16)30661-1"},{"issue":"4","key":"10.1016\/j.clgc.2023.04.013_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0215093","article-title":"Prostate cancer treatment with irreversible electroporation (IRE): safety, efficacy and clinical experience in 471 treatments","volume":"14","author":"Guenther","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.euo.2019.04.008","article-title":"Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort","volume":"3","author":"Blazevski","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"174","key":"10.1016\/j.clgc.2023.04.013_bib0033","first-page":"1","article-title":"First human trial of high-frequency irreversible electroporation therapy for prostate cancer","volume":"17","author":"Dong","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.clgc.2023.04.013_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/bju.13991","article-title":"Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer","volume":"120","author":"Scheltema","year":"2017","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.clgc.2023.04.013_bib0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/bju.13983","article-title":"Focal irreversible electroporation as primary treatment for localized prostate cancer","volume":"121","author":"van den Bos","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2023.04.013_bib0036","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4111\/icu.20210472","article-title":"Focal therapy for prostate cancer with irreversible electroporation: oncological and functional results of a single institution study","volume":"63","author":"Yaxley","year":"2022","journal-title":"Investig Clin Urol"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0037","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1148\/radiol.2019181987","article-title":"Image-guided irreversible electroporation of localized prostate cancer: functional and oncologic outcomes","volume":"292","author":"Collettini","year":"2019","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.clgc.2023.04.013_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12082208","article-title":"Electroporation-based treatments in urology","volume":"12","author":"Kie\u0142bik","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0039","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mric.2018.08.004","article-title":"MR imaging\u2013guided focal therapies of prostate cancer","volume":"27","author":"Mathew","year":"2019","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"1","key":"10.1016\/j.clgc.2023.04.013_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part i: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.04.013_bib0041","article-title":"EAU-EANM-ESTRO-ESUR-ISUP_SIOG guidelines on prostate cancer 2022","author":"Mottet","year":"2022","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:38:35Z","timestamp":1761565115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1558767323001015"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.04.013","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Update on Focal Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}